Patrick E. Cafferty is one of the Firm’s founding partners and has three decades of litigation experience in high profile class action litigation. Mr. Cafferty has represented clients in all the firm’s major industry areas, including pharmaceuticals, airlines, cellular and telephone, financial services, insurance, technology and manufacturing, with recent emphasis on antitrust and consumer fraud and protection.
Mr. Cafferty has been actively involved in a number of the firm’s successful actions, including In re TriCor Indirect Purchaser Antitrust Litigation (D. Del.) (consumer and third party settlement: $65.7 million); In re Relafen Antitrust Litigation (D. Mass.) (consumer and third party settlement: $75 million); In re Cardizem CD Antitrust Litigation (E.D. Mich.) (consumer and third party settlement: $80 million); In re Warfarin Sodium Antitrust Litigation (D. Del.) (consumer and third party payor settlement: $44.5 million), Lorazepam & Clorazepate Antitrust Litig. (D.D.C.) (settlement of consumer and third party, together with Attorney General actions: $135 million); and In re Synthroid Marketing Litigation (N.D. Ill.) (consumer settlement: $84.7 million). In Telesphere Securities Litigation, Judge Milton I. Shadur characterized Mr. Cafferty’s credentials as “impeccable.” 753 F. Supp. 176, 719 (N.D. Ill. 1990).
From 1983 to 1985, Mr. Cafferty served as a prehearing attorney for the Michigan Court of Appeals and as Clerk to Judge Glenn S. Allen, Jr. of that Court.
Education Profile
Mr. Cafferty received his law degree from Michigan State University College of Law (1983, cum laude) and his undergraduate degree from the University of Michigan (1980, with distinction).
Involvement and Memberships
- Michigan Bar Association
- Chicago Bar Association
- Speaker in Washington D.C. at a forum sponsored by Families USA and Blue Cross/Blue Shield styled “Making the Drug Industry Play Fair.”
- Presenter at a Health Action Conference workshop in Washington D.C. titled “Consumers’ Access to Generic Drugs: How Brand Manufacturers Can Derail Generic Drugs and How to Make Them Stay on Track.”
Jurisdictions Admitted to Practice
Mr. Cafferty is licensed to practice in Michigan and Illinois and has been admitted to the United States Supreme Court and numerous federal district and appellate courts.